News

Micro- and nanoplastics in the body are passed on during cell division

Kocher: Neue Finanzierungsvereinbarung mit der Österreichischen Forschungsförderungsgesellschaft (FFG) abgeschlossen

ÖGPath: Digitale und KI-Pathologie brauchen bessere Zugänglichkeit

Women live significantly longer in poor health than men

Sarcura secures a €1.7 M grant from FFG, the Austrian Research Promotion Agency to accelerate miniaturized and autonomous cell therapy manufacturing platform

TAmiRNA to present miND® NextGen sequencing insights to RNA Leaders Europe Congress in Basel

Technoclone receives US FDA Marketing Authorization for the first ADAMTS13 Activity Diagnostic Test

FH Campus Wien: Ergotherapie-basierte App ELSA unterstützt Familien im Umgang mit ADHS

Cellectric, Resistell and Lausanne University Hospital will collaborate on a joint Eurostars project

2024 EMBL Alumni Award recipients announced

Namensänderung: Mylan Österreich GmbH wird zur Viatris Austria GmbH

PIUR IMAGING and GE HealthCare collaborate to advance innovation with 3D thyroid ultrasound imaging

Rare Disease Day 29. Februar 2024: Pro Rare Austria fordert österreichweite Register für seltene Erkrankungen und Datenraum

Houskapreis 2024: 15 Forschungsprojekte nominiert

U.S. CDC Advisory Committee (ACIP) Recommends Use of Valneva’s Single-Dose Chikungunya Vaccine IXCHIQ®

Bewertungsboard in Österreich: Sorgen um Zugang zu innovativen Therapien für seltene Erkrankungen

Significant progress in bionic reconstruction of limb functions

GE HealthCare Showcases Precision Care with Launch of Elevated LOGIQ Ultrasound System Portfolio including PIUR IMAGING “PIUR tUS inside” at European Congress of Radiology 2024

University Hospital Vienna/MedUni Vienna among the top 25 hospitals in the world

CEBINA announces the launch of DanubeNeuro, an acceleration program transforming insightful neuroscience research into novel therapeutics